9th Annual Biomarkers Congress

Oncology: GlaxoSmithKline

Total Score People Score Events Score
20 18 17
Date Event Presentation Speakers
March 19, 2014 3rd Neurological Biomarkers A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways Allen Roses
May 31, 2013 ASCO Annual Meeting 2013 Special Session Catherine Wang
April 6, 2013 AACR Annual Meetings From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Dashyant Dhanak
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC Tona M Gilmer, Axel Hoos
May 10, 2011 5th Annual Conference in Japan for Asian New Drug Development Proposal for Regional Clinical Development in Oncology Hanlim Moon
March 7, 2011 Imaging in Cancer Drug Development The role of PET in drug development Jan Passchier
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Cancer Vaccines: Prophylaxy or Therapy | Development of the MAGE-A3 ASCI: From Tumor Specificity to Predictive Biomarkers Vincent G Brichard
June 9, 2009 Cell and Tissue-Based Assays for HTS Novel Assays and New Technologies Kalpana Patel
Table Six: Novel Assays, New Technologies and their Applications Kalpana Patel
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Use of Cardiac Troponin Measurements in Drug Development For the Detection of Cardiotoxicity John K. Finkle
January 26, 2009 Biomarker Assay Development Development and Integration of Biomarkers into Clinically Useful Diagnostics Anne Marie Martin
January 26, 2009 Translational Cancer Medicine Development and Integration of Biomarkers into Clinically Useful Diagnostics Anne Marie Martin
January 26, 2009 7th Annual Partnering with Central Labs B1 : How to Reduce the Burden on Smaller Sponsor Clinical Team-The Cross Functional Approach Karen Turner
January 5, 2009 High Content Analysis Primary HCS for Immunomodulation Carmel B Nanthakumar
March 25, 2008 Preclinical Development Advances in Liver Toxicity Testing: What’s on the Horizon? Holly L Jordan
March 25, 2008 TRENDS IN DRUG SAFETY Advances in Liver Toxicity Testing: What’s on the Horizon? Holly L Jordan
February 19, 2008 Screening Europe Track B The Industrialisation of 1536 Well Format High Throughput Screening for Modulators of G Protein-Coupled Receptors Stuart Baddeley
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS FOR EARLY CLINICAL TRIALS (08:00-12:15) Vincenzo Libri
BIOMARKERS FOR EARLY CLINICAL TRIALS: Biomarkers in Early Clinical Trials for Dementia (09:05-09:35) Vincenzo Libri
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: Setting the Stage for Adaptive Design Trials (14:00 - 14:30) Judith A. Quinlan
SESSION I: LAYING THE GROUND WORK FOR EARLY DECISION MAKING (13:45 - 19:00) Judith A. Quinlan, Graeme E. Archer
SESSION I: The Use of Bayesian Methods in Go/No-Go Decision Making (15:00 - 15:30) Graeme E. Archer
SESSION II: REGULATORY PERSPECTIVES AND LESSONS LEARNED FROM CONDUCTING STUDIES WITH ADAPTIVE TRIAL DESIGNS (08:30-11:15) Judith A. Quinlan
SESSION II: Co-Chairperson’s Opening Remarks (08:30-08:45) Judith A. Quinlan
CASE STUDIES (11:15-14:45) Judith A. Quinlan
CASE STUDY: Acute Migraine POC Using CRM - The Power of Team Work and a Can Do Attitude... Overcoming Logistical and Operational Hurdles (13:45-14:15) Judith A. Quinlan
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.